Shares of Colgate-Palmolive Co. (NYSE:CL) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $75.33 and last traded at $74.72, with a volume of 2,876,122 shares. The stock had previously closed at $74.47.

CL has been the subject of a number of recent research reports. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, April 20th. Citigroup Inc. raised their target price on Colgate-Palmolive from $78.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, April 14th. Barclays PLC raised their target price on Colgate-Palmolive from $69.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Monday, March 21st. Atlantic Securities initiated coverage on Colgate-Palmolive in a research note on Wednesday, June 1st. They issued an “overweight” rating for the company. Finally, Morgan Stanley reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, April 29th. Eleven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $72.82.

The stock has a market capitalization of $66.73 billion and a P/E ratio of 49.29. The company’s 50-day moving average price is $72.31 and its 200 day moving average price is $69.25.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, April 28th. The company reported $0.63 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.63. The company earned $3.76 billion during the quarter, compared to analyst estimates of $3.76 billion. During the same period last year, the firm earned $0.66 earnings per share. The business’s revenue was down 7.6% compared to the same quarter last year. On average, equities analysts anticipate that Colgate-Palmolive Co. will post $2.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Friday, July 22nd will be issued a $0.39 dividend. The ex-dividend date is Wednesday, July 20th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.09%.

In other news, CTO Patricia Verduin sold 3,666 shares of the business’s stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $72.19, for a total value of $264,648.54. Following the completion of the transaction, the chief technology officer now directly owns 54,602 shares of the company’s stock, valued at $3,941,718.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Justin Skala sold 89,200 shares of the business’s stock in a transaction on Wednesday, May 11th. The stock was sold at an average price of $72.17, for a total value of $6,437,564.00. Following the completion of the transaction, the chief operating officer now directly owns 97,338 shares of the company’s stock, valued at $7,024,883.46. The disclosure for this sale can be found here.

Several institutional investors recently added to or reduced their stakes in the company. First Trust Advisors LP boosted its position in Colgate-Palmolive by 15.2% in the fourth quarter. First Trust Advisors LP now owns 142,087 shares of the company’s stock worth $9,466,000 after buying an additional 18,800 shares during the period. Gamble Jones Investment Counsel boosted its position in Colgate-Palmolive by 0.8% in the fourth quarter. Gamble Jones Investment Counsel now owns 28,715 shares of the company’s stock worth $1,913,000 after buying an additional 219 shares during the period. Busey Trust CO boosted its position in Colgate-Palmolive by 0.3% in the fourth quarter. Busey Trust CO now owns 123,714 shares of the company’s stock worth $8,242,000 after buying an additional 331 shares during the period. Smithfield Trust Co. boosted its position in Colgate-Palmolive by 1.9% in the fourth quarter. Smithfield Trust Co. now owns 19,668 shares of the company’s stock worth $1,310,000 after buying an additional 359 shares during the period. Finally, Geneva Advisors LLC boosted its position in Colgate-Palmolive by 2.7% in the fourth quarter. Geneva Advisors LLC now owns 17,760 shares of the company’s stock worth $1,183,000 after buying an additional 470 shares during the period.

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.